1 – 41 of 41
- show: 100
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Glycemic control and outcome after carotid intervention in patients with T2D : A Swedish nationwide cohort study
(
- Contribution to journal › Article
- 2022
-
Mark
Current and future costs of obesity in Sweden
(
- Contribution to journal › Article
-
Mark
Registry-based randomised clinical trials : a remedy for evidence-based diabetes care?
(
- Contribution to journal › Scientific review
-
Mark
Long-Term Cost Effectiveness of Oral Semaglutide Versus Empagliflozin and Sitagliptin for the Treatment of Type 2 Diabetes in the Swedish Setting
(
- Contribution to journal › Article
- 2021
-
Mark
Diabetes mellitus was not associated with lower amputation-free survival after open revascularization for chronic limb-threatening ischemia : A nationwide propensity score adjusted analysis
(
- Contribution to journal › Article
-
Mark
Higher long-term cardiovascular morbidity after open surgery for intermittent claudication caused by infrainguinal atherosclerotic disease in patients with diabetes - A nationwide observational cohort study
(
- Contribution to journal › Article
-
Mark
The impact of diabetes mellitus on major amputation among patients with chronic limb threatening ischemia undergoing elective endovascular therapy- a nationwide propensity score adjusted analysis
(
- Contribution to journal › Article
-
Mark
Early and long-term prognosis in patients with and without type 2 diabetes after carotid intervention : a Swedish nationwide propensity score matched cohort study
(
- Contribution to journal › Article
-
Mark
A registry-based randomised trial comparing an SGLT2 inhibitor and metformin as standard treatment of early stage type 2 diabetes (SMARTEST): Rationale, design and protocol
(
- Contribution to journal › Article
-
Mark
Reduced expression of OXPHOS and DNA damage genes is linked to protection from microvascular complications in long-term type 1 diabetes : the PROLONG study
(
- Contribution to journal › Article
- 2020
-
Mark
Nationwide comparison of long-term survival and cardiovascular morbidity after acute aortic aneurysm repair in patients with and without type 2 diabetes
(
- Contribution to journal › Article
-
Mark
Worse cardiovascular prognosis after endovascular surgery for intermittent claudication caused by infrainguinal atherosclerotic disease in patients with diabetes
(
- Contribution to journal › Article
-
Mark
Increased Plasma Soluble Interleukin-2 Receptor Alpha Levels in Patients With Long-Term Type 1 Diabetes With Vascular Complications Associated With IL2RA and PTPN2 Gene Polymorphisms
(
- Contribution to journal › Article
-
Mark
Liver nucleotide biosynthesis is linked to protection from vascular complications in individuals with long-term type 1 diabetes
(
- Contribution to journal › Article
- 2019
-
Mark
Long-term Survival and Cardiovascular Morbidity after Elective Open Aortic Aneurysm Repair in Patients with and without Type 2 Diabetes : A Nationwide Propensity-Adjusted Analysis
(
- Contribution to journal › Article
-
Mark
Real-world costs of continuous insulin pump therapy and multiple daily injections for type 1 diabetes : A population-based and propensity-matched cohort from the Swedish National Diabetes Register
(
- Contribution to journal › Article
-
Mark
Survival, cardiovascular morbidity, and reinterventions after elective endovascular aortic aneurysm repair in patients with and without diabetes : A nationwide propensity-adjusted analysis
(
- Contribution to journal › Article
- 2018
-
Mark
Reduced Long-Term Risk of Aortic Aneurysm and Aortic Dissection Among Individuals With Type 2 Diabetes Mellitus : A Nationwide Observational Study
(
- Contribution to journal › Article
- 2015
-
Mark
Does the choice of EQ-5D tariff matter? A comparison of the Swedish EQ-5D-3L index score with UK, US, Germany and Denmark among type 2 diabetes patients.
(
- Contribution to journal › Article
-
Mark
Insulin pump therapy, multiple daily injections, and cardiovascular mortality in 18 168 people with type 1 diabetes: observational study.
(
- Contribution to journal › Article
- 2014
-
Mark
Cost-Utility Analysis of Glucagon-Like Peptide-1 Agonists Compared with Dipeptidyl Peptidase-4 Inhibitors or Neutral Protamine Hagedorn Basal Insulin as Add-On to Metformin in Type 2 Diabetes in Sweden.
2014) In Diabetes therapy : research, treatment and education of diabetes and related disorders 5(2). p.591-607(
- Contribution to journal › Article
-
Mark
Health utilities of type 2 diabetes-related complications: a cross-sectional study in sweden.
(
- Contribution to journal › Article
- 2013
-
Mark
Towards renewed health economic simulation of type 2 diabetes: risk equations for first and second cardiovascular events from Swedish register data.
(
- Contribution to journal › Article
-
Mark
Predicting Changes in Cardiovascular Risk Factors in Type 2 Diabetes in the Post-UKPDS Era: Longitudinal Analysis of the Swedish National Diabetes Register.
(
- Contribution to journal › Article
- 2012
-
Mark
Different methods to present the effect of blood pressure on cardiovascular diseases by Cox regression.
(
- Contribution to journal › Article
-
Mark
Blood pressure and risk of cardiovascular diseases in type 2 diabetes: further findings from the Swedish National Diabetes Register (NDR-BP II).
(
- Contribution to journal › Article
-
Mark
Increased Urine IgM and IgG(2) Levels, Indicating Decreased Glomerular Size Selectivity, Are Not Affected by Dalteparin Therapy in Patients with Type 2 Diabetes.
(
- Contribution to journal › Article
- 2011
-
Mark
Trends in blood pressure control in patients with type 2 diabetes - Data from the Swedish National Diabetes Register (NDR).
(
- Contribution to journal › Article
-
Mark
Blood lipids in 75,048 type 2 diabetic patients: a population-based survey from the Swedish National diabetes register
(
- Contribution to journal › Article
- 2010
-
Mark
Cancer är vanligare vid diabetes. Kanske spelar själva behandlingen också en roll.
(
- Contribution to journal › Article
-
Mark
Systolic blood pressure and risk of cardiovascular diseases in type 2 diabetes: an observational study from the Swedish national diabetes register.
(
- Contribution to journal › Article
-
Mark
Glycemic Control and Cardiovascular Disease in 7,454 Patients With Type 1 Diabetes An observational study from the Swedish National Diabetes Register (NDR)
(
- Contribution to journal › Article
- 2009
-
Mark
Effect of tight control of HbA1c and blood pressure on cardiovascular diseases in type 2 diabetes: An observational study from the Swedish National Diabetes Register (NDR)
(
- Contribution to journal › Article
-
Mark
Smoking as an independent risk factor for myocardial infarction or stroke in type 2 diabetes: a report from the Swedish National Diabetes Register.
(
- Contribution to journal › Article
- 2008
-
Mark
Vad är egentligen en optimal behandling vid typ 2-diabetes? Nya studier manar till eftertanke.
(
- Contribution to journal › Article
- 2007
-
Mark
Glycemic and risk factor control in type 1 diabetes - Results from 13,612 patients in a national diabetes register
(
- Contribution to journal › Article
-
Mark
Beneficial effects of dalteparin on haemostatic function and local tissue oxygenation in patients with diabetes, severe vascular disease and foot ulcers
(
- Contribution to journal › Article
- 2005
-
Mark
Predictors of successful long-term blood pressure control in type 2 diabetic patients: data from the Swedish National Diabetes Register (NDR).
(
- Contribution to journal › Article
- 2004
-
Mark
Nationella diabetesregistret 1996-2003. Kvalitetsvärdering visar att diabetesvården har forbättrats
(
- Contribution to journal › Article
- 2003
-
Mark
The National Diabetes Register in Sweden: An implementation of the St. Vincent Declaration for Quality Improvement in Diabetes Care.
(
- Contribution to journal › Article
-
Mark
Effect of Dalteparin on Healing of Chronic Foot Ulcers in Diabetic Patients With Peripheral Arterial Occlusive Disease: A prospective, randomized, double-blind, placebo-controlled study.
(
- Contribution to journal › Article